NMD Pharma
Risskov
About NMD Pharma
NMD Pharma is a clinical-stage biotech company that delivers life-transforming therapies for people living with neuromuscular diseases. They use ClC-1 Cl- ion channel inhibitors to treat neuromuscular diseases. Their translational muscle electrophysiology platform leverages in-depth knowledge of muscle physiology and muscular disorders to identify and develop first-class therapeutics for neuromuscular diseases that are unmet medically.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $171.5M
- Funding stage: Early Stage Venture
- Last round: Series B (Nov 2023)
- Website: nmdpharma.com
- Phone: 603-820-0298
Industries & Categories
Medical, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/nmd-pharma-7253 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.